Closing Bell: Knight Therapeutics Inc down on Friday (GUD)
Today during trading, Knight Therapeutics Inc shares closed at $5.55 after opening the day at $5.80. Intraday prices ranged from $5.50 to $5.80.
Share prices eased -2.12% from the previous day's close of $5.67.
During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.37% at 5446.68, the Dow Jones Industrial Average closed -1.21% at 40347.97 and the Nasdaq Composite closed -2.30% at 17194.15.
Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.
A total of 64,994 shares was traded during the last trading day, with total trades of 342, with an average volume of 52,858 over 5 days.
The TSX overall saw 741 price advancers against 4,512 declines and 69 unchanged.
During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, in the last 52 weeks, Knight Therapeutics Inc's shares have advanced 15.62%, while they have advanced 6.94% this year.
Following today's trading, Knight Therapeutics Inc has a market capitalization of $574.80 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.
Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.
Based on 4.00 analysts, Knight Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
